Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 10, 2022PLoS MedicineOpen Access

Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies

View Full Paper
Ask AI
Bookmark
Share

Authors

IBIsabel BergeriWorld Health OrganizationMWMairead WhelanUniversity of CalgaryLSLorenzo SubissiWorld Health Organization - Pakistan

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bergeri et al. (2022) studied this question.

synapsesocial.com/papers/6a97fc9bf4ab474a3623b003https://doi.org/10.1371/journal.pmed.1004107
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Coronavirus Pandemic (COVID-19)2021 · 1,615 citations
  2. 2SARS-CoV-2 and Plasmodium falciparum common immunodominant regions may explain low COVID-19 incidence in the malaria-endemic belt2020 · 84 citations
  3. 3R: A Language and Environment for Statistical Computing2000 · 363,590 citations
  4. 4SeroTracker‐RoB : A decision rule‐based algorithm for reproducible risk of bias assessment of seroprevalence studies2023 · 15 citations
  5. 5Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis2021 · 272 citations